SA pharmaceutical manufacturer Adcock Ingram has joined an international coalition of generic drugmakers pledging to work together to accelerate access to Covid-19 treatments for low and middle-income countries via the non-profit Medicines Patent Pool (MPP). 

The MPP was launched 10 years ago by the global health initiative Unitaid, funded by a levy on airline tickets. It has previously struck deals with several pharmaceutical companies to share their patents on treatments for HIV, tuberculosis, and hepatitis C with generic manufacturers in low and middle-income countries, including Adcock Ingram, which signed an agreement to make the HIV treatment dolutegravir...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now